— COMPANY
“Safe, Simple & Affordable Cell Therapy”
TCUBEit Inc. is a biotech startup company focusing on T cell-based immuno-therapy.
T cells in the human body examine cancers or infections and rid them from the body.
We are dedicated to curating both the quantity & quality of T cells from patients.
Sun Taek Kim Ph.D.
Founder/CEO
Founder/CEO
Dr. Kim is the founder and CEO of TCUBEit which focuses on innovative T cell-based immuno-therapy. He has worked on adoptive T cell therapy and molecular recognition in immune system with over 25 years of T cell immunology field experience.
Before TCUBEit, he served as the CTO of the M5 Bioscience Group, a Principal Scientist at Medytox Inc., and worked as an Invited Scientist of T Cell Biology for the Korea Research Institute of Bioscience and Biotechnology. He has initiated and led multiple drug development projects on autoimmunity and immuno-oncology as the principal investigator in both academia and biopharmaceutical industry.
Dr. Kim received his Ph.D. from KAIST in immunology and biophysics. During his Ph.D., he studied antibody engineering and structure modeling at the Biomolecular Engineering Research Institute in Osaka, Japan. He worked as an instructor of Dana-Farber Cancer Institute and Harvard Medical School, investigating the molecular architecture and signaling mechanism of the T cell receptor TCR and CD3 subunits
Research Team Members
Name of Company : TCUBEit Inc.
Establishment : October 18, 2019
Employees : 17 people (5 PhD, 5 Masters, 5 B.S…)
Address
HQ : Sejong SB Plaza | #904, Sejong
R&D/Production : C&V Center | Osong, Cheongju | Republic of Korea
Main Business
Next-gen T cell Manufacturing Platform | T-CAMP, T-GUNS
Pipelines for HCC and gastric cancer
Human Immunity Profiling